Updated systematic review and meta-analysis of extended adjuvant temozolomide in patients with newly diagnosed glioblastoma
T Gupta, JMP Selvarajan, S Kannan… - Neuro-Oncology …, 2023 - academic.oup.com
Background Contemporary standard-of-care for newly diagnosed glioblastoma (GBM) is
maximal safe resection followed by postoperative focal conformal radiotherapy (RT) plus …
maximal safe resection followed by postoperative focal conformal radiotherapy (RT) plus …
A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed …
L Gately, C Mesía, JM Sepúlveda, S Del Barco… - Journal of Neuro …, 2024 - Springer
Purpose The optimal duration of post-radiation temozolomide in newly diagnosed
glioblastoma remains unclear, with no published phase III randomised trials. Standard-of …
glioblastoma remains unclear, with no published phase III randomised trials. Standard-of …